EdgarLookup

US Foods Holding Corp. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that US Foods Holding Corp. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
1.7%
Profit Margin
Net income ÷ revenue
4.8%
Return on Assets
Net income ÷ assets
2.24x
Debt-to-Equity
Total liabilities ÷ equity
+4.1%
Revenue Growth
Year over year

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2025 Dec 27, 2025 $39.42B Feb 12, 2026
FY2025 Dec 28, 2024 $37.88B Feb 12, 2026
FY2025 Dec 30, 2023 $35.60B Feb 12, 2026
FY2024 Dec 31, 2022 $34.06B Feb 13, 2025
FY2023 Jan 1, 2022 $29.49B Feb 15, 2024
FY2022 Jan 2, 2021 $22.89B Feb 17, 2023
FY2019 Dec 28, 2019 $6.93B Feb 13, 2020
FY2019 Sep 28, 2019 $6.53B Feb 13, 2020
FY2019 Jun 29, 2019 $6.44B Feb 13, 2020
FY2019 Mar 30, 2019 $6.03B Feb 13, 2020

Revenue (Net Sales)

Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.

Fiscal Year Period End Value Filed
FY2017 Dec 30, 2017 $6.00B Feb 27, 2018
FY2017 Sep 30, 2017 $6.20B Feb 27, 2018
FY2017 Jul 1, 2017 $6.16B Feb 27, 2018
FY2017 Apr 1, 2017 $5.79B Feb 27, 2018
FY2017 Dec 31, 2016 $5.68B Feb 27, 2018
FY2017 Oct 1, 2016 $5.84B Feb 27, 2018
FY2017 Jul 2, 2016 $5.81B Feb 27, 2018
FY2017 Apr 2, 2016 $5.59B Feb 27, 2018
FY2016 Jan 2, 2016 $5.94B Feb 28, 2017
FY2016 Sep 26, 2015 $5.80B Feb 28, 2017

Gross Profit

Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.

Fiscal Year Period End Value Filed
FY2025 Dec 27, 2025 $6.86B Feb 12, 2026
FY2025 Dec 28, 2024 $6.53B Feb 12, 2026
FY2025 Dec 30, 2023 $6.15B Feb 12, 2026
FY2024 Dec 31, 2022 $5.49B Feb 13, 2025
FY2023 Jan 1, 2022 $4.66B Feb 15, 2024
FY2022 Jan 2, 2021 $3.72B Feb 17, 2023
FY2019 Dec 28, 2019 $1.24B Feb 13, 2020
FY2019 Sep 28, 2019 $1.16B Feb 13, 2020
FY2019 Jun 29, 2019 $1.14B Feb 13, 2020
FY2019 Mar 30, 2019 $1.05B Feb 13, 2020

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 27, 2025 $676.00M Feb 12, 2026
FY2025 Dec 28, 2024 $494.00M Feb 12, 2026
FY2025 Dec 30, 2023 $506.00M Feb 12, 2026
FY2024 Dec 31, 2022 $265.00M Feb 13, 2025
FY2023 Jan 1, 2022 $164.00M Feb 15, 2024
FY2022 Jan 2, 2021 ($226.00M) Feb 17, 2023
FY2019 Dec 28, 2019 $92.00M Feb 13, 2020
FY2019 Sep 28, 2019 $106.00M Feb 13, 2020
FY2019 Jun 29, 2019 $116.00M Feb 13, 2020
FY2019 Mar 30, 2019 $71.00M Feb 13, 2020

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Dec 27, 2025 $1.20B Feb 12, 2026
FY2025 Dec 28, 2024 $1.10B Feb 12, 2026
FY2025 Dec 30, 2023 $1.02B Feb 12, 2026
FY2024 Dec 31, 2022 $594.00M Feb 13, 2025
FY2023 Jan 1, 2022 $424.00M Feb 15, 2024
FY2022 Jan 2, 2021 ($77.00M) Feb 17, 2023
FY2021 Dec 28, 2019 $699.00M Feb 17, 2022
FY2020 Dec 29, 2018 $658.00M Feb 16, 2021
FY2019 Dec 30, 2017 $588.00M Feb 13, 2020
FY2018 Dec 31, 2016 $419.00M Feb 14, 2019

SG&A Expense

Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.

Fiscal Year Period End Value Filed
FY2025 Dec 27, 2025 $5.63B Feb 12, 2026
FY2025 Dec 28, 2024 $5.41B Feb 12, 2026
FY2025 Dec 30, 2023 $5.12B Feb 12, 2026
FY2024 Dec 31, 2022 $4.89B Feb 13, 2025
FY2023 Jan 1, 2022 $4.22B Feb 15, 2024
FY2022 Jan 2, 2021 $3.76B Feb 17, 2023
FY2021 Dec 28, 2019 $3.89B Feb 17, 2022
FY2020 Dec 29, 2018 $3.65B Feb 16, 2021
FY2019 Dec 30, 2017 $3.63B Feb 13, 2020
FY2018 Dec 31, 2016 $3.58B Feb 14, 2019

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 27, 2025 $1.37B Feb 12, 2026
FY2025 Dec 28, 2024 $1.17B Feb 12, 2026
FY2025 Dec 30, 2023 $1.14B Feb 12, 2026
FY2024 Dec 31, 2022 $765.00M Feb 13, 2025
FY2023 Jan 1, 2022 $419.00M Feb 15, 2024
FY2022 Jan 2, 2021 $413.00M Feb 17, 2023
FY2021 Dec 28, 2019 $760.00M Feb 17, 2022
FY2020 Dec 29, 2018 $609.00M Feb 16, 2021
FY2019 Dec 30, 2017 $749.00M Feb 13, 2020
FY2018 Dec 31, 2016 $549.00M Feb 14, 2019

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2025 Dec 27, 2025 $410.00M Feb 12, 2026
FY2025 Dec 28, 2024 $341.00M Feb 12, 2026
FY2025 Dec 30, 2023 $309.00M Feb 12, 2026
FY2024 Dec 31, 2022 $265.00M Feb 13, 2025
FY2023 Jan 1, 2022 $274.00M Feb 15, 2024
FY2022 Jan 2, 2021 $189.00M Feb 17, 2023
FY2021 Dec 28, 2019 $258.00M Feb 17, 2022
FY2020 Dec 29, 2018 $235.00M Feb 16, 2021
FY2019 Dec 30, 2017 $221.00M Feb 13, 2020
FY2018 Dec 31, 2016 $164.00M Feb 14, 2019

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 27, 2025 $13.94B Feb 12, 2026
FY2025 Dec 28, 2024 $13.44B Feb 12, 2026
FY2024 Dec 30, 2023 $13.19B Feb 13, 2025
FY2023 Dec 31, 2022 $12.77B Feb 15, 2024
FY2022 Jan 1, 2022 $12.52B Feb 17, 2023
FY2021 Jan 2, 2021 $12.42B Feb 17, 2022
FY2020 Dec 28, 2019 $11.29B Feb 16, 2021
FY2019 Dec 29, 2018 $9.19B Feb 13, 2020
FY2018 Dec 30, 2017 $9.04B Feb 14, 2019
FY2017 Dec 31, 2016 $8.94B Feb 27, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 27, 2025 $9.64B Feb 12, 2026
FY2025 Dec 28, 2024 $8.91B Feb 12, 2026
FY2024 Dec 30, 2023 $8.44B Feb 13, 2025
FY2023 Dec 31, 2022 $8.28B Feb 15, 2024
FY2022 Jan 1, 2022 $8.25B Feb 17, 2023
FY2021 Jan 2, 2021 $8.37B Feb 17, 2022
FY2020 Dec 28, 2019 $7.58B Feb 16, 2021
FY2019 Dec 29, 2018 $5.96B Feb 13, 2020
FY2018 Dec 30, 2017 $6.29B Feb 14, 2019
FY2017 Dec 31, 2016 $6.41B Feb 27, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 27, 2025 $4.31B Feb 12, 2026
FY2025 Dec 28, 2024 $4.53B Feb 12, 2026
FY2025 Dec 30, 2023 $4.75B Feb 12, 2026
FY2025 Dec 31, 2022 $3.96B Feb 12, 2026
FY2024 Jan 1, 2022 $3.74B Feb 13, 2025
FY2023 Jan 2, 2021 $3.53B Feb 15, 2024
FY2022 Dec 28, 2019 $3.71B Feb 17, 2023
FY2021 Dec 29, 2018 $3.23B Feb 17, 2022
FY2020 Dec 30, 2017 $2.75B Feb 16, 2021
FY2019 Dec 31, 2016 $2.54B Feb 13, 2020

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 27, 2025 $5.79B Feb 12, 2026
FY2025 Dec 28, 2024 $5.77B Feb 12, 2026
FY2024 Dec 30, 2023 $5.70B Feb 13, 2025
FY2023 Dec 31, 2022 $5.63B Feb 15, 2024
FY2022 Jan 1, 2022 $5.63B Feb 17, 2023
FY2021 Jan 2, 2021 $5.64B Feb 17, 2022
FY2020 Dec 28, 2019 $4.73B Feb 16, 2021
FY2019 Dec 29, 2018 $3.97B Feb 13, 2020
FY2018 Dec 30, 2017 $3.97B Feb 14, 2019
FY2017 Dec 31, 2016 $3.91B Feb 27, 2018

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 27, 2025 $2.68B Feb 12, 2026
FY2025 Dec 28, 2024 $2.00B Feb 12, 2026
FY2024 Dec 30, 2023 $1.51B Feb 13, 2025
FY2023 Dec 31, 2022 $1.01B Feb 15, 2024
FY2022 Jan 1, 2022 $782.00M Feb 17, 2023
FY2021 Jan 2, 2021 $661.00M Feb 17, 2022
FY2020 Dec 28, 2019 $916.00M Feb 16, 2021
FY2019 Dec 29, 2018 $531.00M Feb 13, 2020
FY2018 Dec 30, 2017 $124.00M Feb 14, 2019
FY2017 Dec 31, 2016 ($136.46M) Feb 27, 2018

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 27, 2025 $41.00M Feb 12, 2026
FY2025 Dec 28, 2024 $59.00M Feb 12, 2026
FY2025 Dec 30, 2023 $269.00M Feb 12, 2026
FY2024 Dec 31, 2022 $211.00M Feb 13, 2025
FY2022 Jan 1, 2022 $148.00M Feb 17, 2023
FY2021 Jan 2, 2021 $828.00M Feb 17, 2022
FY2020 Dec 28, 2019 $90.00M Feb 16, 2021
FY2019 Dec 29, 2018 $104.00M Feb 13, 2020
FY2018 Dec 30, 2017 $119.00M Feb 14, 2019
FY2017 Dec 31, 2016 $131.09M Feb 27, 2018

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2017 Dec 30, 2017 $3.80B Feb 27, 2018
FY2017 Dec 31, 2016 $3.80B Feb 27, 2018
FY2016 Jan 2, 2016 $4.73B Feb 28, 2017

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 27, 2025 2 Feb 12, 2026
FY2025 Dec 28, 2024 2 Feb 12, 2026
FY2025 Dec 30, 2023 2 Feb 12, 2026
FY2024 Dec 31, 2022 1 Feb 13, 2025
FY2023 Jan 1, 2022 0 Feb 15, 2024
FY2022 Jan 2, 2021 (1) Feb 17, 2023
FY2019 Dec 28, 2019 0 Feb 13, 2020
FY2019 Sep 28, 2019 0 Feb 13, 2020
FY2019 Jun 29, 2019 0 Feb 13, 2020
FY2019 Mar 30, 2019 0 Feb 13, 2020

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 27, 2025 2 Feb 12, 2026
FY2025 Dec 28, 2024 2 Feb 12, 2026
FY2025 Dec 30, 2023 2 Feb 12, 2026
FY2024 Dec 31, 2022 1 Feb 13, 2025
FY2023 Jan 1, 2022 0 Feb 15, 2024
FY2022 Jan 2, 2021 (1) Feb 17, 2023
FY2019 Dec 28, 2019 0 Feb 13, 2020
FY2019 Sep 28, 2019 0 Feb 13, 2020
FY2019 Jun 29, 2019 0 Feb 13, 2020
FY2019 Mar 30, 2019 0 Feb 13, 2020

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 27, 2025 220.50M Feb 12, 2026
FY2025 Dec 28, 2024 230.50M Feb 12, 2026
FY2024 Dec 30, 2023 245.10M Feb 13, 2025
FY2023 Dec 31, 2022 225.00M Feb 15, 2024
FY2022 Jan 1, 2022 223.00M Feb 17, 2023
FY2021 Jan 2, 2021 221.00M Feb 17, 2022
FY2020 Dec 28, 2019 220.00M Feb 16, 2021
FY2019 Dec 29, 2018 217.00M Feb 13, 2020
FY2018 Dec 30, 2017 215.00M Feb 14, 2019
FY2017 Dec 31, 2016 220.93M Feb 27, 2018